Dr. Wargo runs a translational research laboratory studying the genetics of melanoma and other cancers with the goal of understanding what makes them able to grow, spread, and evade the immune system. Based on the findings from her laboratory, she is now using genetic targeted therapy to arrest the growth of these cancers and to make them more visible to the immune system. She is currently developing clinical trials incorporating what she has learned in the laboratory to treat patients with cancer. Her efforts in this regard have been nationally recognized, and she has several research grants for this work.
In addition to her important work in the laboratory, Dr. Wargo has focused on minimally-invasive surgical techniques for the treatment of skin diseases, including skin cancer. As part of the Surgical Oncology department at MD Anderson Cancer Center, she has contributed to improving management for patients with skin cancer and other skin disease.
Mobile users can navigate this website by clicking on the menu button in the top-left corner of the screen.